News | August 30, 2021
Granules India receives approval from Health Canada for arthritis drug
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
The government plans to enrol over 50 crore people and empanel more hospitals under the scheme. The scheme provides a cover of Rs 5 lakh per family per year
The collaboration will support Canada with direct access to rapid pandemic response capabilities
ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses
Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.
Partnership combines Apexon's agentic AI platforms and cloud modernization tools with AWS infrastructure to accelerate AI deployment, clinical innovation, and digital transformation across healthcare and life sciences
With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
